Extending Therapeutic Utility Of Psychostimulants

Authors: Huma Ikram, Adnan Maqsood Choudhry, Darakhshan Jabeen Haleem

UNIVERSITY OF KARACHI,
DALHOUSIE UNIVERSITY, HALIFAX, NOVA SCOTIA, CANADA B3H 4R2;
NEUROSCIENCE RESEARCH LABORATORY, DR. PANJWANI CENTER FOR MOLECULAR MEDICINE AND DRUG RESEARCH, UNIVERSITY OF KARACHI,

Volume 18 | Issue 4

Published: November 6, 2026

Abstract

O)CNS stimulants (Psychostimulants) are psychoactive drugs which induce temporary improvements in either mental or physical function or both. Although considered as drugs of abuse, psychostimulants could also be used for the pharmacotherapy of various pathological conditions. They are considered as drugs of choice especially in cases where resistance to primary treatment develops and patients stop responding to those pharmacotherapeutic agents [1]. Psychostimulants, have the edge in this regard as few of them (like apomorphine) produce sensitization (a potentiation of behavior) rather than tolerance [2]. This makes them potential candidates for the treatment of various disorders like use of apomorphine for the treatment of Parkinson’s/ related motor disorders [3], methylphenidate for the treatment of attention-deficit hyperactivity disorder (ADHD), depressive symptoms, narcolepsy, obesity and postural orthostatic tachycardia syndrome [4].

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)